British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology..
Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Rheumatology (Oxford, England) - (2024) vom: 16. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Price, Elizabeth J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Connective tissue disease |
|---|
| Anmerkungen: |
Date Revised 15.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1093/rheumatology/keae152 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371108306 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371108306 | ||
| 003 | DE-627 | ||
| 005 | 20240416233458.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240416s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/rheumatology/keae152 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1377.xml |
| 035 | |a (DE-627)NLM371108306 | ||
| 035 | |a (NLM)38621708 | ||
| 035 | |a (PII)keae152 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Price, Elizabeth J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology. | ||
| 520 | |a Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Sjögren disease | |
| 650 | 4 | |a Sjögren’s syndrome | |
| 650 | 4 | |a connective tissue disease | |
| 650 | 4 | |a guideline | |
| 650 | 4 | |a management | |
| 650 | 4 | |a recommendations | |
| 650 | 4 | |a treatment | |
| 700 | 1 | |a Benjamin, Stuart |e verfasserin |4 aut | |
| 700 | 1 | |a Bombardieri, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Bowman, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Carty, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Ciurtin, Coziana |e verfasserin |4 aut | |
| 700 | 1 | |a Crampton, Bridget |e verfasserin |4 aut | |
| 700 | 1 | |a Dawson, Annabel |e verfasserin |4 aut | |
| 700 | 1 | |a Fisher, Benjamin A |e verfasserin |4 aut | |
| 700 | 1 | |a Giles, Ian |e verfasserin |4 aut | |
| 700 | 1 | |a Glennon, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Monica |e verfasserin |4 aut | |
| 700 | 1 | |a Hackett, Katie L |e verfasserin |4 aut | |
| 700 | 1 | |a Larkin, Genevieve |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, Wan-Fai |e verfasserin |4 aut | |
| 700 | 1 | |a Ramanan, Athimalaipet V |e verfasserin |4 aut | |
| 700 | 1 | |a Rassam, Saad |e verfasserin |4 aut | |
| 700 | 1 | |a Rauz, Saaeha |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Guy |e verfasserin |4 aut | |
| 700 | 1 | |a Sutcliffe, Nurhan |e verfasserin |4 aut | |
| 700 | 1 | |a Tappuni, Anwar |e verfasserin |4 aut | |
| 700 | 1 | |a Walsh, Stephen B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology (Oxford, England) |d 1999 |g (2024) vom: 16. Apr. |w (DE-627)NLM102581908 |x 1462-0332 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:16 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/rheumatology/keae152 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 16 |c 04 | ||